Favorite
0 Like
Facebook
Tweet
Print

Dinner Symposium: Advances in the Treatment of HER2-Positive Breast Cancer - Ticketed event. Limited seating.

Saturday, November 3

6:45 PM - 8:45 PM

Location: Great Hall 1 & 2

Faculty(s)

Reshma Mahtani, DO

Associate Professor of Medicine
Sylvester Cancer Center, University of Miami
Lisa Hineman, RN, MSN, AOCN, PHN, ANP-C

Oncology Nurse Practitioner/Director of Clinical Operations
Los Angeles Cancer Network

This activity is supported by an educational grant from Puma Biotechnology, Inc.

Learning Objectives:

Discuss the clinical significance of existing and emerging data in HER2+ breast cancer
Develop a strategy to effectively manage diarrhea and other adverse events associated with treatments for HER2+ breast cancer
Implement best practices for the management of HER2+ breast cancer brain metastases

ViewAttendees 13 Slides Take Notes

Favorite
0 Like
Tweet
Print

Reshma Mahtani, DO

Associate Professor of Medicine
Sylvester Cancer Center, University of Miami

Presentation(s):

Dinner Symposium: Advances in the Treatment of HER2-Positive Breast Cancer - Ticketed event. Limited seating.
Saturday, November 3
6:45 PM – 8:45 PM

ViewAttendees 13 Slides Take Notes

Send Email for Reshma Mahtani

Subject

Body

Normal text
Bold Italic Underline

Favorite
0 Like
Tweet
Print

Lisa Hineman, RN, MSN, AOCN, PHN, ANP-C

Oncology Nurse Practitioner/Director of Clinical Operations
Los Angeles Cancer Network

Lisa D. Hineman, RN, MSN, AOCN, PHN, ANP-C

Lisa D. Hineman is an Oncology Nurse Practitioner and Director of Clinical Operations with Los Angeles Cancer Network. She received herMaster’s in Nursing and Nurse Practitioner’s education California State University, Los Angeles.
She has been involved with ONS since 1984 local and national as GLAONS President, OCN and AOCN of the Year, National ONS Liaison to Washington DC.
Her awards include the “Donald L. Bogdon Cancer Survivor Award” for contributing to the community’s better health and cancer education, Astra Zeneca "Visions of Hope Award” for contribution and service to the breast cancer community, Soroptimist International of Glendale “Ruby Award for Advancing and Improving the Lives of Women and Girls”, “Avella ‘C.A.R.E’ Award for Outstanding Nurses”.
She has volunteered in Glendale and Greater Los Angeles since 1984 with various organizations.
Lisa lectures nationally on cancer therapies, symptom management, health promotion and improving outcomes.

Presentation(s):

Dinner Symposium: Advances in the Treatment of HER2-Positive Breast Cancer - Ticketed event. Limited seating.
Saturday, November 3
6:45 PM – 8:45 PM

ViewAttendees 13 Slides Take Notes

Send Email for Lisa Hineman

Subject

Body

Normal text
Bold Italic Underline

<h1>  shared a speaker with you!</h1><div><b>Name:</b> Lisa Hineman</div><div><b>Organization:</b> Los Angeles Cancer Network</div><div><b>Position:</b> Oncology Nurse Practitioner/Director of Clinical Operations</div><div><b>Bio:</b> Lisa D. Hineman, RN, MSN, AOCN, PHN, ANP-C

Lisa D. Hineman is an Oncology Nurse Practitioner and Director of Clinical Operations with Los Angeles Cancer Network.  She received herMaster’s in Nursing and Nurse Practitioner’s education California State University, Los Angeles. 
She has been involved with ONS since 1984 local and national as GLAONS President, OCN and AOCN of the Year, National ONS Liaison to Washington DC.
Her awards include the “Donald L. Bogdon Cancer Survivor Award” for contributing to the community’s better health and cancer education, Astra Zeneca "Visions of Hope Award” for contribution and service to the breast cancer community, Soroptimist International of Glendale “Ruby Award for Advancing and Improving the Lives of Women and Girls”,  “Avella ‘C.A.R.E’ Award for Outstanding Nurses”.
She has volunteered in Glendale and Greater Los Angeles since 1984 with various organizations.
Lisa lectures nationally on cancer therapies, symptom management, health promotion and improving outcomes.  </div>

Assets